InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,186.55
(
-0.12%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gi197845

Send PM Follow Ignore
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

gi197845

Re: None

Friday, 08/18/2017 4:06:29 PM

Friday, August 18, 2017 4:06:29 PM

Post# of 20617
The announcement of the Fluticare launch in Q4 is not increasing the share price, probably because the Fluticare ANDA approval has already been hyped so much and because of the excessive and massive dilution as compared to just last year at this same time.

It appears that the only thing that will raise the share price is actual profits.

It also appears that the FDA has been bribed by Bayer and GSK, to delay the Fluticare ANDA approval or denial to the very last second, of the very last day, so possible ANDA approval will occur by 12/31/2018.

Thank you.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up